Tecfidera Lymphocyte Chart Review
Public ClinicalTrials.gov record NCT02519413. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Retrospective, Multi-Center, Observational Study to Assess the Effect of Tecfidera® Delayed-Release Capsules on Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis (REALIZE)
Study identification
- NCT ID
- NCT02519413
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 483 participants
Conditions and interventions
Conditions
Interventions
- dimethyl fumarate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2015
- Primary completion
- Jan 31, 2016
- Completion
- Jan 31, 2016
- Last update posted
- Aug 25, 2016
2015 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research site | Homewood | Alabama | 35209 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | Atlanta | Georgia | 30309 | — |
| Research Site | Buffalo | New York | 14203 | — |
| Research Site | Patchogue | New York | 11772 | — |
| Research Site | Huntersville | North Carolina | 28078 | — |
| Research Site | Philadelphia | Pennsylvania | 19125 | — |
| Research Site | Seattle | Washington | 98101 | — |
| Research Site | Seattle | Washington | 98104 | — |
| Research Site | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02519413, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2016 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02519413 live on ClinicalTrials.gov.